Abstract 1801: STK-012, an A/b-Selective IL-2 Activates Tumor Antigen Specific CD25+ CD8 T Cells to Reject Tumors Without Acute Vascular ToxicityMartin Oft,Navneet Ratti,Sandro Vivona,Jan Emmerich,Romina Riener, Ievgen O. Koliesnik,Scott McCauley,Michele Bauer,Marie Semana,Deepti Rokkam,Bhargavi Jayaraman,Rene de Waal Malefyt,Paul-Joseph Aspuria, Michael Totagrande,Anita Mehta-Damani,Patrick J. Lupardus,Rob A. KasteleinCancer Research（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
